"ከተሳካ AT-527 ህሙማንን ቀድሞ ለማከም ፣ የኢንፌክሽን እድገትን ለመቀነስ እና በጤና ስርዓቶች ላይ አጠቃላይ ሸክም ለመቀነስ አስተዋፅኦ ሊያደርግ ይችላል" ብለዋል ።
"If successful, AT-527 could help treat patients early, reduce the progression of the infection, and contribute to decreasing the overall burden on health systems," indicated Roche in a press release.